The National Institute on Alcohol Abuse and Alcoholism has issued the “Wearable Alcohol Biosensor” Challenge in the search for a wearable or otherwise discreet device capable of measuring blood alcohol levels in real time. An improved wearable biosensor would aid researchers and clinicians by providing more accurate data on how much study participants and patients are drinking. The winning prototype...
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), components of the National Institutes of Health, have collaborated with HBO to create an eye-opening documentary, ADDICTION, to air on Thursday, March 15 (9:00-10:30 p.m. ET/PT). The documentary, developed with funding support from the Robert Wood Johnson Foundation, seeks to help Americans understand...
Brain molecules similar to the active compound in marijuana help to regulate alcohol consumption, according to new reports by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), Bethesda, Maryland, and a separate NIAAA-supported group at several New York state research institutions. In studies conducted with a strain of mice known to have a high preference for alcohol...
Washington, D.C. Jeffrey C. Long, Ph.D., David Goldman, M.D., and coworkers in the Laboratory of Neurogenetics, Division of Intramural Clinical and Biological Research, NIAAA, report in this month's Neuropsychiatric Genetics (Volume 81, Number 3) highly suggestive evidence in one region of chromosome 11 and good evidence in one region of chromosome 4 for linkage to alcohol dependence (commonly termed alcoholism)...
Although genetic feedback has been evaluated as an adjunct to smoking cessation interventions, its efficacy for reducing alcohol-related risks is unknown. The current study evaluated the feasibility, acceptability, and efficacy of a web-based alcohol intervention incorporating genetic feedback and risk information specific to ALDH2 genotype. The ALDH2*2 variant is associated with partial protection against alcohol dependence but confers significantly increased...
News Advisory Updated Guide Offers Clinicians New Tools to Help Patients With Alcohol Problems What: Announces update of Helping Patients Who Drink Too Much: A Clinician’s Guide, produced by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH). Why: The updated Guide includes a new medications management program that consists of brief...
Home General Info Agenda Accommodations and Logistics Contact Registration Recommended Reading Our Sponsors 2017 National Conference on Alcohol and Opioid Use in Women & Girls: Advances in Prevention, Treatment and Recovery Research October 26 - 27, 2017 Washington Marriott at Metro Center Washington, DC As a follow-up to the 2008 National Conference on Preventing Substance-exposed Pregnancies sponsored by the ICCFASD...
Data Access Policy, Application and Agreement NIAAA Protocol NCIG 001: A Multisite Double-Blind, Placebo-Controlled Trial of Quetiapine Fumarate XR in Very Heavy-Drinking Alcohol-Dependent Patients Description This double-blind, randomized placebo-controlled trial evaluated the efficacy and safety of quetiapine, for the treatment of alcohol use disorder (AUD). Study Details Sponsor: The National Institute on Alcohol Abuse and Alcoholism’s Clinical Investigations Group (NCIG) ...
The Division of Metabolism and Health Effects (DMHE) develops scientific initiatives and supports basic and translational research on the health consequences of alcohol consumption and metabolism, with the goal of improving human health and well-being. The DMHE supports research on the health effects of alcohol that may result from a single dose, chronic or binge drinking behavior emphasizing metabolic pathways...